From: TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer
Clinicopathological | Univariate Analysis | Multivariate Analysis | ||
---|---|---|---|---|
 | HR (95% CI) | P value | HR (95% CI) | P value |
Age | 1.018 | 0.398 | 1.005 | 0.835 |
  (< 60 vs ≥ 60) | (0.977–1.060) |  | (0.963–1.048) | |
Gender | 0.623 | 0.308 | 0.377 | 0.119 |
  (Female vs Male) | (0.251–1.546) |  | (0.111–1.283) | |
Grade | 1.756 | 0.445 | 0.189 | 0.069 |
  (Low vs High) | (0.414–7.440) |  | (0.031–1.142) | |
T | 2.174 | 0.041 | 2.066 | 0.431 |
  (T1-T2 vs T3-T4) | (1.032–4.578) |  | (0.340–12.558) | |
N | 2.889 | 0.042 | 2.199 | 0.259 |
  (N0 vs N1) | (1.041–8.018) |  | (0.559–8.639) | |
Stage | 3.647 | 0.007 | 1.927 | 0.549 |
  (I-II vs III-IV) | (1.435–9.269) |  | (0.226–16.442) | |
TEAD4 Expression | 4.112 | 0.002 | 3.786 | 0.015 |
  (Low vs High) | (1.673–10.106) | (1.292–11.091) |